FDA Expands Approval of Drug to Stave Off Type 1 Diabetes
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
Administering a daily injection of insulin or wearing some form of insulin pump might be irritating, but they are far better than having to deal with some of the serious…
Administering a daily injection of insulin or wearing some form of insulin pump might be irritating, but they are far better than having to deal with some of the serious…